4//SEC Filing
McCann Corey 4
Accession 0001062993-23-001039
CIK 0001835567other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:03 PM ET
Size
9.0 KB
Accession
0001062993-23-001039
Insider Transaction Report
Form 4
McCann Corey
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-01-14+88,000→ 8,245,565 total - Exercise/Conversion
Restricted Stock Units
2023-01-14−88,000→ 178,667 total→ Common Stock (88,000 underlying)
Holdings
- 986,517(indirect: By Trust)
Class A Common Stock
- 1,685,913(indirect: By Trust)
Class A Common Stock
Footnotes (5)
- [F1]The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
- [F2]Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
- [F3]Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
- [F4]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F5]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881049
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 5:03 PM ET
- Size
- 9.0 KB